News Focus
News Focus
icon url

$5.95akadawson-m

05/16/24 12:48 PM

#232371 RE: $5.95akadawson-m #232370

Hey Grip IT; have you noticed the share price today, 18 cents...
icon url

Grip it and Sip It

05/16/24 1:14 PM

#232372 RE: $5.95akadawson-m #232370

This letter is version #325 of the same nonsense! All “plan to”, “hope to” etc! This serves two purposes:

1) spin the baggies into a lather over $.18 stock
2) warrant and gifted shares are being unloaded on the pump! Educate yourself and look at the price JayJay needs to sell at! Then follow the Form S-4 down the road!

Schools out! You’ve been warned. Come Monday, $.13-.14 and reality hits. Enjoy the day of green before the implosion
icon url

djjazzyjeff

05/16/24 2:14 PM

#232379 RE: $5.95akadawson-m #232370

You have any idea how many times this company has said "we expect" only for it never to materialize you complete buffoon? A lot.
icon url

justdafactss

05/16/24 4:34 PM

#232385 RE: $5.95akadawson-m #232370

Yes lets review the pumper talk bolded in red---

Over the next six months, we expect to commence at least one, and potentially two clinical trials. The prospective clinical trials, in order of priority, are: (i) a Phase II study of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer; and (ii) a Phase II study exploring leronlimab’s effects on inflammation. The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication.

This sentence: "The Company’s priority will be the oncology trial which, if successful, will put us on track towards a commercial approval of leronlimab in that indication."


(sigh) Dupes will never learn....